Product Information
HYSINGLA ER 100 MG TABLET is a brand product labeled by Purdue Pharma LP, priced at $62.0951 per EA under NDC 59011027660. Its NADAC has been published 69 times since Nov 20, 2024.
Strength
100 mg/1
Manufacturer
Purdue Pharma LPNDC
59011027660
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA206627On Market Since
1/15/2015
Pharmacological Classes
Price Statistics
The NADAC for HYSINGLA ER 100 MG TABLET has been published 69 times since Nov 20, 2024, and over the history we have for it it has risen 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $62.0951 per EA |
|---|---|
| All-time high | $62.0951 (Mar 11, 2026) |
| All-time low | $53.8640 (Dec 18, 2024) |
| 52-week high | $62.0951 |
| 52-week low | $57.2305 |
| Median price | $57.2305 |
| Average price | $57.6050 |
| Largest weekly change | +8.5% (Jan 7, 2026) |
| Weeks tracked | 69 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hydrocodone bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HYSINGLA ER 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYSINGLA ER 100 MG TABLET, manufactured by Purdue Pharma LP, is $62.0951 per EA (NDC 59011027660), effective Mar 11, 2026.
How has the price of HYSINGLA ER 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYSINGLA ER 100 MG TABLET has risen 14.9%. It has been tracked across 69 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for HYSINGLA ER 100 MG TABLET?
Since Nov 20, 2024, the NADAC for HYSINGLA ER 100 MG TABLET has ranged from a low of $53.8640 (Dec 18, 2024) to a high of $62.0951 (Mar 11, 2026), with a median of $57.2305 per EA.
Are there cheaper alternatives to HYSINGLA ER 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYSINGLA ER 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures HYSINGLA ER 100 MG TABLET?
HYSINGLA ER 100 MG TABLET (NDC 59011027660) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.
Related Drugs
Same classification